Exclusive Coverage articles provide quick insight and additional author perspectives on select studies recently published in Journal of Clinical Oncology and Journal of Oncology Practice.
From Illumination to Innovation: Visualizing the Future — The 2015 Presidential Address by Peter Paul Yu, MD, FACP, FASCO
30 May 2015 04:12 PM
Watch an exclusive video of Dr. Peter Yu delivering his Presidential Address at the 51st Annual Meeting of the American Society of Clinical Oncology.
Children Treated for ALL Experience Varying Levels of Cognitive Deficits—and Genetic Susceptibility to Oxidative Stress Might be a Factor
18 May 2015 04:23 PM
Numerous studies have shown that children treated for acute lymphoblastic leukemia (ALL) experience increased rates of cognitive deficits in terms of attention span, working memory, and processing complex information.
Benefits of Intraperitoneal Chemotherapy Extend Beyond 10 Years; Survival Increases with Number of Cycles
11 May 2015 04:12 PM
Several clinical trials have shown that for women with ovarian cancer, IP chemotherapy–which allows the drugs to be delivered directly into the peritoneum at a 20- to 1000-fold greater concentration than IV chemotherapy—confers survival advantages.
04 May 2015 04:09 PM
During the past two decades, there has been an increase in the number of long-term survivors of autologous and allogeneic hematopoietic stem-cell transplantations (HSCT).
No Difference in Survival Between Cisplatin and Carboplatin for Metastatic or Recurrent Cervical Cancer
27 Apr 2015 04:02 PM
For women with metastatic or recurrent cervical cancer, paclitaxel plus carboplatin confers the same survival advantage as paclitaxel plus cisplatin, currently the standard of care (overall survival [OS] was 17.5 months in the carboplatin group versus 18.3 months in the cisplatin group)...
13 Apr 2015 04:12 PM
The study found that among the 35% of patients who expressed a strong desire for genetic testing, 196 (43.4%) did not have a relevant discussion...
06 Apr 2015 03:20 PM
A study in the Journal of Clinical Oncology (JCO) set out to answer two questions: What are the rates of adherence to these new distress-screening and referral requirements at two tertiary cancer care centers and, do clinicians find the screening useful?
23 Mar 2015 04:57 PM
“Physicians who are part of a larger, more integrated care delivery system might be better able to plan a response to a drug shortage. Another possibility is that larger organizations have more purchasing power or ability to engage in the market.”
JCO Exclusive: Testosterone Matters: Keeping Levels Low Among Men with Prostate Cancer Improves Survival
16 Mar 2015 05:01 PM
Among patients with prostate cancer being treated with continuous (non-intermittent) androgen deprivation therapy, those whose testosterone dipped to a nadir of less than 20 nanograms per deciliter within the first year of treatment experienced improved survival and . . .
09 Mar 2015 05:06 PM
For children and adolescents being treated for acute lymphoblastic leukemia, those who receive a stem-cell transplant from an unrelated donor have the same overall survival as those who receive the transplant from a sibling.